Loading...

Pfizer Inc.

PFENYSE
Healthcare
Drug Manufacturers - General
$24.25
$0.71(3.04%)

Pfizer Inc. (PFE) Stock Overview

Explore Pfizer Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 73.7/100

Key Financials

Market Cap140.6B
P/E Ratio13.13
EPS (TTM)$1.38
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Week$23.39
1 Month$23.37
3 Months$25.31
1 Year Target$24.15

PFE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Pfizer Inc. (PFE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 37.71, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $24.15.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.13 and a market capitalization of 140.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;